New Drug May Boost Survival a Bit for Some With Advanced Lung Cancer

SUNDAY, Sept. 27, 2015 — A new study finds that the cancer drug nivolumab (Opdivo) extends the lives of some patients with advanced lung cancer for several months.
In a head-to-head comparison, patients treated with nivolumab lived an average of…
Source: Topamax